Disclosures for "Assessment of the Potential for Drug–Drug Interactions Between INP104 and Gepants for Migraine Management Using a Model-based Approach")
-
Dr. Ray has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Ray has stock in Impel Pharmaceuticals.
-
Brad Torphy has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Amgen. Brad Torphy has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Brad Torphy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Brad Torphy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Brad Torphy has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Abbvie. Brad Torphy has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Amgen. Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Brad Torphy has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Brad Torphy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Brad Torphy has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. The institution of Brad Torphy has received research support from Amgen. The institution of Brad Torphy has received research support from Teva. The institution of Brad Torphy has received research support from Theranica. The institution of Brad Torphy has received research support from Abbvie.
-
Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lilly. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Currax. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Relivion. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nerivio. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axiome. Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Joshi has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Joshi has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Joshi has received research support from Lilly . The institution of Dr. Joshi has received research support from Biohaven. The institution of Dr. Joshi has received research support from Amgen.
-
Dr. Vann has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Vann has received personal compensation for serving as an employee of Biogen.
-
Mr. Downing has received personal compensation for serving as an employee of Impel Pharmaceuticals .
-
Ms. Fonseca has received personal compensation for serving as an employee of Impel Pharmaceuticals. Ms. Fonseca has stock in Impel Pharmaceuticals.
-
Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
-
Dr. Aurora has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Aurora has stock in Impel Neurpharma.